The DOI matches its Crossref record; 378 of the 378 references it cites were found in a registry or an index.
Mechanisms of Autoantibody-Induced Pathology
Open accessAbstract
Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves' disease. Overall, more than 2.5% of the population is affected by autoantibody-driven autoimmune disease. Pathways leading to autoantibody-induced pathology greatly differ among different diseases, and autoantibodies directed against the same antigen, depending on the targeted epitope, can have diverse effects. To foster knowledge in autoantibody-induced pathology and to encourage development of urgently needed novel therapeutic strategies, we here categorized autoantibodies according to their effects. According to our algorithm, autoantibodies can be classified into the following categories: (1) mimic receptor stimulation, (2) blocking of neural transmission, (3) induction of altered signaling, triggering uncontrolled (4) microthrombosis, (5) cell lysis, (6) neutrophil activation, and (7) induction of inflammation. These mechanisms in relation to disease, as well as principles of autoantibody generation and detection, are reviewed herein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–378 of 378
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
Hazenbos, W. L. W., Heijnen, I., Meyer, D., Hofhuis, F. M., de Lavalette, C. R., Schmidt, R. E., Capel, P. J., van de Winkel, J. G. J., Gessner, J. E., van den Berg, T. K., et al. (1998) · PubMed · Cited by 137
T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
Heß, C., Winkler, A., Lorenz, A. K., Holecska, V., Blanchard, V., Eiglmeier, S., Schoen, A.-L., Bitterling, J., Stoehr, A. D., Petzold, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65938 · Cited by 136
Self-citationManto, M. U., Dalmau, J. O., Didelot, A., Rogemond, V., & Honnorat, J. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-31 · Cited by 136
Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction
Heupel, W.-M., Zillikens, D., Drenckhahn, D., & Waschke, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1825 · Cited by 136
Cataland, S. R., Holers, V. M., Geyer, S. M., et al. (2014) · Blood · doi:10.1182/blood-2013-12-547067 · Cited by 135
Moscato, E. H., Jain, A., Peng, X., Hughes, E. G., Dalmau, J. O., & Balice‐Gordon, R. J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07349.x · Cited by 134
Crystal structure of the TSH receptor bound to a blocking type TSHR autoantibody
Sanders, P. W., Young, S., Sanders, J. F., Kabelis, K., Baker, S., Sullivan, A., Evans, M., Clark, J., Wilmot, J., Hu, X., et al. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-10-0127 · Cited by 134
Central B-Cell Tolerance: Where Selection BeginsPreprint
Pelanda, R., & Torres, R. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007146 · Cited by 134
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
Müller, J., & Nitschke, L. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.54 · Cited by 133
Davies, T. F., & MORSHED, S. A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1559633 · Cited by 133
Epidemiology of myasthenia gravis in Ontario, Canada
Breiner, A., Widdifield, J., Katzberg, H. D., Barnett, C., Bril, V., & Tu, K. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.10.009 · Cited by 132
Evans, M. K., Sanders, J. F., Tagami, T., Sanders, P. W., Young, S., Roberts, E., Wilmot, J., Hu, X., Kabelis, K., Clark, J., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03831.x · Cited by 131
Schwab, I., Mihai, S., Seeling, M., Kasperkiewicz, M., Ludwig, R. J., & Nimmerjahn, F. (2014) · European Journal of Immunology · doi:10.1002/eji.201344230 · Cited by 129
Self-citationNew Estimates of Incidence of Encephalitis in England
Granerød, J., Cousens, S., Davies, N. W. S., Crowcroft, N. S., & Thomas, S. L. (2013) · Emerging infectious diseases · doi:10.3201/eid1909.130064 · Cited by 129
Rapoport, B., Alsabeh, R., Aftergood, D., & McLachlan, S. M. (2000) · Thyroid · doi:10.1089/10507250050137761 · Cited by 129
Self-citationMori, S., Kubo, S., Akiyoshi, T., Yamada, S., Miyazaki, T., Hotta, H., Desaki, J., Kishi, M., Konishi, T., Nishino, Y., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.031 · Cited by 129
Myocarditis: Infection Versus Autoimmunity
Rose, N. R. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9339-z · Cited by 127
Schiviz, A. N., Wuersch, K., Piskernik, C., Dietrich, B., Hoellriegl, W., Rottensteiner, H., Scheiflinger, F., Schwarz, H. P., & Muchitsch, E. M. (2012) · Blood · doi:10.1182/blood-2011-09-380535 · Cited by 125
Meyer, D., Schiller, C., Westermann, J., Izui, S., Hazenbos, W. L. W., Verbeek, J. S., Schmidt, R. E., & Gessner, J. E. (1998) · Blood · doi:10.1182/blood.v92.11.3997 · Cited by 124
Günther, J., Kill, A., Becker, M. O., Heidecke, H., Rademacher, J., Siegert, E., Radić, M., Burmester, G. R., Dragun, D., & Riemekasten, G. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4503 · Cited by 124
Self-citationGenetic deficiency of Syk protects mice from autoantibody‐induced arthritis
Jakus, Z., Simon, E., Balázs, B., & Mócsai, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27438 · Cited by 122
Impact of autoantibody glycosylation in autoimmune diseases
Goulabchand, R., Vincent, T., Batteux, F., Eliaou, J., & Guilpain, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.02.005 · Cited by 121
Woodley, D. T., Chang, C., Saadat, P., Ram, R., Liu, Z., & Chen, M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23702.x · Cited by 120
Murine IgG1 Complexes Trigger Immune Effector Functions Predominantly via FcγRIII (CD16)
Hazenbos, W. L. W., Heijnen, I., Meyer, D., Hofhuis, F. M., de Lavalette, C. R., Schmidt, R. E., Capel, P. J., van de Winkel, J. G. J., Gessner, J. E., van den Berg, T. K., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3026 · Cited by 120
Sanders, D. B., Burns, T. M., Cutter, G., Massey, J. M., Juel, V. C., Hobson‐Webb, L. D., & The Muscle Study Group (2013) · Muscle & Nerve · doi:10.1002/mus.23944 · Cited by 119
The Role of Antibodies in Mouse Models of Rheumatoid Arthritis, and Relevance to Human Disease
Monach, P. A., Benoist, C. O., & Mathis, D. J. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82005-4 · Cited by 118
Ben‐Smith, A., Dove, S. K., Martin, A., Wakelam, M. J. O., & Savage, C. O. S. (2001) · Blood · doi:10.1182/blood.v98.5.1448 · Cited by 115
Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis
Villalta, D., Imbastaro, T., Giovanni, S. D., Lauriti, C., Gabini, M., Turi, M. C., & Bizzaro, N. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.07.005 · Cited by 114
Chazenbalk, G. D., Pichurin, P. N., Chen, C., Latrofa, F., Johnstone, A. P., McLachlan, S. M., & Rapoport, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215745 · Cited by 113
Self-citationProteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis
Millet, A., Martin, K., Bonnefoy, F., Saas, P., Mocek, J., Alkan, M., Terrier, B., Kerstein-Staehle, A., Tamassia, N., Satyanarayanan, S. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78182 · Cited by 112
Self-citationNovel autoantibodies and clinical phenotypes in adult and juvenile myositis
Betteridge, Z., Gunawardena, H., & McHugh, N. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3275 · Cited by 112
Tüzün, E., Scott, B. G., Goluszko, E., Higgs, S., & Christadoss, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3847 · Cited by 111
Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption
Wallukat, G., Reinke, P., Dörffel, Y., Luther, H. P., Bestvater, K., Felix, S. B., & Baumann, G. (1996) · International Journal of Cardiology · doi:10.1016/0167-5273(96)02598-3 · Cited by 111
Gene Expression in Bronchoalveolar Lavage Cells from Scleroderma Patients
Luzina, I. G., Atamas, S. P., Wise, R. A., Wigley, F. M., Xiao, H. Q., & White, B. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.4683 · Cited by 111
Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options
Kasperkiewicz, M., Sadik, C. D., Bieber, K., Ibrahim, S. M., Manz, R. A., Schmidt, E., Zillikens, D., & Ludwig, R. J. (2016) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.356 · Cited by 111
Self-citationEpidermolysis Bullosa Acquisita: A Retrospective Clinical Analysis of 30 Cases
Kim, S., Kim, J.-H., & Kim, Y. H. (2011) · Acta Dermato Venereologica · doi:10.2340/00015555-1065 · Cited by 108
Beéck, K. O. D., Vermeersch, P., Verschueren, P., Westhovens, R., Mariën, G., Blockmans, D., & Bossuyt, X. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.013 · Cited by 108
Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen, V. T., Arredondo, J., Chernyavsky, A. I., Kitajima, Y., Pittelkow, M. R., & Grando, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309000200 · Cited by 108
The search for new antigenic targets in myasthenia gravis
Cossins, J., Belaya, K., Zoltowska, K. M., Koneczny, I., Maxwell, S., Jacobson, L. W., Leite, M. I., Waters, P. J., Vincent, A. C., & Beeson, D. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06833.x · Cited by 106
p38MAPK Signaling and Desmoglein-3 Internalization Are Linked Events in Pemphigus Acantholysis
Jolly, P. S., Berkowitz, P., Bektas, M., Lee, H.-E., Chua, M., Diaz, L. A., & Rubenstein, D. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087999 · Cited by 105
Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique
Kalantari‐Dehaghi, M., Anhalt, G. J., Camilleri, M., Chernyavsky, A. I., Chun, S., Felgner, P. L., Jasinskas, A., Leiferman, K. M., Liang, L., Marchenko, S. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057587 · Cited by 105
Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
Ludwig, R. J. (2013) · ISRN Dermatology · doi:10.1155/2013/812029 · Cited by 104
Self-citationHerlyn, K., Buckert, F., Gross, W. L., et al. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/ket440 · Cited by 101
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
Chapin, J. C., Weksler, B. B., MAGRO, C. M. J., & Laurence, J. C. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09084.x · Cited by 100
CD4+ T Cells and Cytokines in the Pathogenesis of Acquired Myasthenia Gravis
Conti‐Fine, B. M., Milani, M., & Wang, W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1405.042 · Cited by 99
Scheid, J. F., Mouquet, H., Kofer, J., Yurasov, S., Nussenzweig, M. C., & Wardemann, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113395108 · Cited by 97
Desmoglein 3–specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice
Takahashi, H., Kouno, M., Nagao, K., Wada, N. A., Hata, T., Nishimoto, S., Iwakura, Y., Yoshimura, A., Yamada, T., Kuwana, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57379 · Cited by 96
Deletion of Syk in Neutrophils Prevents Immune Complex Arthritis
Elliott, E., Ziffle, J. V., Scapini, P., Sullivan, B. M., Locksley, R. M., & Lowell, C. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100341 · Cited by 96
Spindler, V., Rötzer, V., Dehner, C. A., Kempf, B., Gliem, M., Radeva, M. Y., Hartlieb, E., Harms, G. S., Schmidt, E., & Waschke, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60139 · Cited by 95
Self-citationTiller, T., Kofer, J., Kreschel, C., Busse, C. E., Riebel, S., Wickert, S., Oden, F., Mertes, M. M. M., Ehlers, M., & Wardemann, H. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100171 · Cited by 93
Kasperkiewicz, M., Nimmerjahn, F., Wende, S., Hirose, M., Iwata, H., Jonkman, M. F., Samavedam, U. K. S. R. L., Gupta, Y., Möller, S., Rentz, E., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4023 · Cited by 93
Self-citationLuo, J., Taylor, P., Losen, M. H., Baets, M. H. D., Shelton, G. D., & Lindstrom, J. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2833-09.2009 · Cited by 91
Self-citationTradtrantip, L., Ratelade, J., Zhang, H., & Verkman, A. S. (2012) · Annals of Neurology · doi:10.1002/ana.23741 · Cited by 89
Self-citationImplication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis
Cufi, P., Dragin, N., Weiss, J. M., Martínez‐Martínez, P., Baets, M. H. D., Roussin, R., Fadel, É., Berrih‐Aknin, S., & Panse, R. L. (2012) · Annals of Neurology · doi:10.1002/ana.23791 · Cited by 89
Zakarija, M., McKenzie, J. M., & Eidson, M. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1239 · Cited by 87
Guptill, J. T., Soni, M., & Meriggioli, M. N. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0398-y · Cited by 86
Jennings, J. M., Tucker, D. K., Kottke, M. D., Saito, M., Delva, E., Hanakawa, Y., Amagai, M., & Kowalczyk, A. P. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.389 · Cited by 85
Hao, J., Meng, L., Xu, P., Chen, M., & Zhao, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038317 · Cited by 85
Cabral-Marques, O., & Riemekasten, G. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.005 · Cited by 85
Self-citationBehnert, A., Schiffer, M., Müller‐Deile, J., Beck, L. H., Mähler, M., & Fritzler, M. J. (2014) · Journal of Immunology Research · doi:10.1155/2014/143274 · Cited by 84
Turcu, A. F., Kumar, S., Neumann, S., Coenen, M., Iyer, S., Chiriboga, P., Gershengorn, M. C., & Bahn, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1149 · Cited by 84
BAFF and the plasticity of peripheral B cell tolerance
Stadanlick, J. E., & Cancro, M. P. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.015 · Cited by 84
Sagan, S. A., Winger, R. C., Cruz-Herranz, A., Nelson, P. A., Hagberg, S., Miller, C. N., Spencer, C. M., Ho, P. P.-K., Bennett, J. L., Levy, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617859114 · Cited by 84
Self-citationIshii, K., Lin, C., Siegel, D. L., & Stanley, J. R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701132 · Cited by 83
Schulze, F. S., Beckmann, T., Nimmerjahn, F., Ishiko, A., Collin, M., Köhl, J., Goletz, S., Zillikens, D., Ludwig, R. J., & Schmidt, E. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.05.007 · Cited by 83
Self-citationBruin, M. C. A., Bierings, M., Uiterwaal, C. S. P. M., Révész, T., Bode, L. G. M., Wiesman, M., Kuijpers, T. W., Tamminga, R. Y. J., & de Haas, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05235.x · Cited by 81
The carbohydrate switch between pathogenic and immunosuppressive antigen‐specific antibodies
Collin, M., & Ehlers, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12171 · Cited by 81
Bontscho, J., Schreiber, A., Manz, R. A., Schneider, W., Luft, F. C., & Kettritz, R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010034 · Cited by 81
Self-citationZeka, B., Hastermann, M., Hochmeister, S., Kögl, N., Kaufmann, N. C., Schanda, K., Mader, S., Misu, T., Rommer, P. S., Fujihara, K., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1501-5 · Cited by 81
Diagnosis and classification of autoimmune orchitis
Silva, C. A., Cocuzza, M., de Carvalho, J. F., & Bonfá, E. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.024 · Cited by 79
Mumtaz, I. M., Hoyer, B. F., Panne, D., Moser, K., Winter, O., Cheng, Q., Yoshida, T., Burmester, G. R., Radbruch, A., Manz, R. A., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.010 · Cited by 79
Self-citationOptimization of current and future therapy for autoimmune diseases
Steinman, L., Merrill, J. T., McInnes, I. B., & Peakman, M. (2012) · Nature Medicine · doi:10.1038/nm.2625 · Cited by 79
Kopecki, Z., Arkell, R. M., Powell, B. C., & Cowin, A. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.461 · Cited by 78
Prevalence of thyroid hormone autoantibodies in healthy subjects
Sakata, S., Matsuda, M., Ogawa, T., Takuno, H., Matsul, I., Sarui, H., & Yasuda, K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02558.x · Cited by 76
Activating and inhibitory FcγRs in autoimmune disorders
Nimmerjahn, F. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0052-1 · Cited by 76
Self-citationTersteeg, C., Schiviz, A. N., Meyer, S. F. D., Plaimauer, B., Scheiflinger, F., Rottensteiner, H., & Vanhoorelbeke, K. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306014 · Cited by 75
Self-citationIgG1 protects against renal disease in a mouse model of cryoglobulinaemia
Strait, R. T., Posgai, M. T., Mahler, A. M., Barasa, N., Jacob, C. O., Köhl, J., Ehlers, M., Stringer, K. F., Shanmukhappa, S. K., Witte, D. P., et al. (2014) · Nature · doi:10.1038/nature13868 · Cited by 73
Taddeo, A., Khodadadi, L., Voigt, C., Mumtaz, I. M., Cheng, Q., Moser, K., Alexander, T., Manz, R. A., Radbruch, A., Hiepe, F., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0551-3 · Cited by 73
Self-citationAutoantibodies Contribute to the Immunopathogenesis of Experimental Dry Eye Disease
Stern, M. E., Schaumburg, C. S., Siemasko, K. F., Gao, J., Wheeler, L. A., Grupe, D. A., de Paiva, C. S., Calder, V. L., Calonge, M., Niederkorn, J. Y., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9299 · Cited by 72
B-cell tolerance: mechanisms and implications
Basten, A., & Silveira, P. A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.001 · Cited by 72
Kulkarni, U., Karsten, C. M., Kohler, T. P., Hammerschmidt, S., Bommert, K., Tiburzy, B., Meng, L., Thieme, L., Recke, A., Ludwig, R. J., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.018 · Cited by 72
Self-citationImmunoadsorption in Dermatology
Meyersburg, D., Schmidt, E., Kasperkiewicz, M., & Zillikens, D. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01075.x · Cited by 71
Self-citationDeubner, N., Berliner, D., Schlipp, A., Gelbrich, G., Caforio, A. L. P., Felix, S. B., Fu, M., Katus, H. A., Angermann, C. E., Lohse, M. J., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq072 · Cited by 70
Regulation of autoreactive antibodies
Yurasov, S., & Nussenzweig, M. C. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328277ef3b · Cited by 70
Jaume, J. C., Kakinuma, A., Chazenbalk, G. D., Rapoport, B., & McLachlan, S. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3740 · Cited by 69
Self-citationInduction of p38MAPK and HSP27 Phosphorylation in Pemphigus Patient Skin
Berkowitz, P., Diaz, L. A., Hall, R. P., & Rubenstein, D. S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701080 · Cited by 69
The synaptic muscle‐specific kinase (MuSK) complex: New partners, new functions
Strochlic, L., Cartaud, A., & Cartaud, J. (2005) · BioEssays · doi:10.1002/bies.20305 · Cited by 69
Rosetti, F., Tsuboi, N., Chen, K., Nishi, H., Ernandez, T., Sethi, S. M., Croce, K., Stavrakis, G., Alcocer-Varela, J. C., Gómez‐Martín, D., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201594 · Cited by 69
Sezin, T., Krajewski, M. P., Wutkowski, A., Mousavi, S., Chakievska, L., Bieber, K., Ludwig, R. J., Dahlke, M., Rades, D., Schulze, F. S., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.021 · Cited by 69
Self-citationA Pathophysiologic Role for Epidermal Growth Factor Receptor in Pemphigus Acantholysis
Bektas, M., Jolly, P. S., Berkowitz, P., Amagai, M., & Rubenstein, D. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438010 · Cited by 68
IVIG in autoimmune disease — Potential next generation biologics
Zuercher, A. W., Spirig, R., Morelli, A. B., & Käsermann, F. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.018 · Cited by 67
Automated Indirect Immunofluorescence Evaluation of Antinuclear Autoantibodies on HEp-2 Cells
Voigt, J., Krause, C. D., Rohwäder, E., Saschenbrecker, S., Hahn, M., Danckwardt, M., Feirer, C., Ens, K., Fechner, K., Barth, E., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/651058 · Cited by 66
LRP4 in neuromuscular junction and bone development and diseases
Shen, C., Xiong, W., & Mei, L. (2015) · Bone · doi:10.1016/j.bone.2015.05.012 · Cited by 65
Pathological autoantibodies in cardiomyopathy
Jahns, R., Boivin, V., Schwarzbach, V., Ertl, G., & Lohse, M. J. (2008) · Autoimmunity · doi:10.1080/08916930802031603 · Cited by 65
MAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris
Mao, X., Li, H., Sano, Y., Gaestel, M., Park, J. M., & Payne, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.224 · Cited by 65
Experimental autoimmune myositis in SJL/J mice.
Rosenberg, N. L., Ringel, S. P., & Kotzin, B. L. (1987) · PubMed · Cited by 65
Sanders, J. F., Evans, M. K., Betterle, C., Sanders, P. W., Bhardwaja, A., Young, S., Roberts, E., Wilmot, J., Richards, T., Kiddie, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0327 · Cited by 64
Complement and cytokine response in acute T hrombotic T hrombocytopenic P urpura
Westwood, J., Langley, K., Heelas, E., Machin, S. J., & Scully, M. (2013) · British Journal of Haematology · doi:10.1111/bjh.12707 · Cited by 64
Komorowski, L., Teegen, B., Probst, C., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.10.011 · Cited by 64
Self-citationGilbert, J. A., Gianoukakis, A. G., Salehi, S., Moorhead, J., Rao, P. V., Khan, M., McGregor, A. M., Smith, T. J., & Banga, J. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5084 · Cited by 63
Casina, V. C., Hu, W., Mao, J., Lu, R., Hanby, H. A., Pickens, B., Kan, Z.-Y., Lim, W. K., Mayne, L. C., Ostertag, E. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512561112 · Cited by 63
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis
Schupp, J. C., Becker, M. O., Günther, J., Müller–Quernheim, J., Riemekasten, G., & Prasse, A. (2014) · European Respiratory Journal · doi:10.1183/09031936.00131713 · Cited by 63
Self-citationDesmoglein-1, differentiation, and disease
Hammers, C. M., & Stanley, J. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69071 · Cited by 62
Self-citationFerrari, S., Palavra, K., Gruber, B., Hovinga, J. A. K., Knöbl, P., Caron, C., Cromwell, C., Aledort, L. M., Plaimauer, B., Turecek, P. L., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.094151 · Cited by 61
Kim, J. H., Kim, Y. H., Kim, S. I., Noh, E. B., Kim, S., Vorobyev, A., Schmidt, E., Zillikens, D., & Kim, S. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04617.x · Cited by 59
Self-citationYamagami, J., Payne, A. S., Kacir, S., Ishii, K., Siegel, D. L., & Stanley, J. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44425 · Cited by 59
Chen, Y., Chernyavsky, A. I., Webber, R. J., Grando, S. A., & Wang, P. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668061 · Cited by 58
Natural autoantibodies and associated B cells in immunity and autoimmunity
Mannoor, K., Xu, Y., & Chen, C. (2012) · Autoimmunity · doi:10.3109/08916934.2012.748753 · Cited by 57
Iwata, H., Bieber, K., Tiburzy, B., Chrobok, N. L., Kalies, K., Shimizu, A., Leineweber, S., Ishiko, A., Vorobyev, A., Zillikens, D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300310 · Cited by 57
Self-citationReview: Progress in the treatment of myasthenia gravis
Gold, R., Hohlfeld, R., & Toyka, K. V. (2008) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608093888 · Cited by 56
Animal models of antineutrophil cytoplasm antibody-associated vasculitis
Salama, A. D., & Little, M. A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834d2d52 · Cited by 55
Metcalfe, R., Jordan, N., Watson, P., Güllü, S., Wiltshire, M., Crisp, M. S., Evans, C., Weetman, A. P., & Ludgate, M. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8411 · Cited by 55
Khodadadi, L., Cheng, Q., Alexander, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135081 · Cited by 54
Kordas, G., Lagoumintzis, G., Sideris, S., Poulas, K. A., & Tzartos, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108327 · Cited by 54
Robles, D. T., Eisenbarth, G. S., Garnes, N. D., Peterson, L. B., & Wicker, L. S. (2003) · Diabetes · doi:10.2337/diabetes.52.3.882 · Cited by 54
Samavedam, U. K. S. R. L., Kalies, K., Scheller, J., Sadeghi, H., Gupta, Y., Jonkman, M. F., Schmidt, E., Westermann, J., Zillikens, D., Rose‐John, S., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.08.002 · Cited by 53
Self-citationYu, X., Holdorf, K., Kasper, B., Zillikens, D., Ludwig, R. J., & Petersen, F. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.230 · Cited by 52
Self-citationAnimal Models of Graves' Hyperthyroidism
Nagayama, Y. (2007) · Thyroid · doi:10.1089/thy.2007.0161 · Cited by 51
Sadeghi, H., Lockmann, A., Hund, A., Samavedam, U. K. S. R. L., Pipi, E., Vafia, K., Hauenschild, E., Kalies, K., Pas, H. H., Jonkman, M. F., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402688 · Cited by 51
Self-citationClobetasol promotes remyelination in a mouse model of neuromyelitis optica
Yao, X., Su, T., & Verkman, A. S. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0309-4 · Cited by 50
Self-citationEmerging treatments for pemphigoid diseases
Ludwig, R. J., Kalies, K., Köhl, J., Zillikens, D., & Schmidt, E. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.003 · Cited by 49
Self-citationBieber, K., Witte, M., Sun, S., Hundt, J. E., Kalies, K., Dräger, S., Kasprick, A., Twelkmeyer, T., Manz, R. A., König, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38357 · Cited by 48
Self-citationvan Koppen, C. J., de Gooyer, M. E., Karstens, W.-J. F., Plate, R., Conti, P. G., van Achterberg, T. A. E., van Amstel, M., Brands, J. H. G. M., Wat, J. W. Y., Berg, R. J. W., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01709.x · Cited by 47
Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
Gomez, A. M., Willcox, N., Molenaar, P. C., Buurman, W. A., Martínez‐Martínez, P., Baets, M. H. D., & Losen, M. H. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06824.x · Cited by 46
Samavedam, U. K. S. R. L., Iwata, H., Müller, S., Schulze, F. S., Recke, A., Schmidt, E., Zillikens, D., & Ludwig, R. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301556 · Cited by 45
Self-citationVitamin B12 and Pernicious Anemia — The Dawn of Molecular Medicine
Bunn, H. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1315544 · Cited by 45
Ghazanfari, N., Morsch, M., Reddel, S., Liang, S., & Phillips, W. D. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270207 · Cited by 44
Schaller, M. M., Vogel, M., Kentouche, K., Lämmle, B., & Hovinga, J. A. K. (2014) · Blood · doi:10.1182/blood-2014-04-561142 · Cited by 44
Krause, C. D., Ens, K., Fechner, K., Voigt, J., Fraune, J., Rohwäder, E., Hahn, M., Danckwardt, M., Feirer, C., Barth, E., et al. (2015) · Lupus · doi:10.1177/0961203314559635 · Cited by 43
Kopecki, Z., Arkell, R. M., Strudwick, X. L., Hirose, M., Ludwig, R. J., Kern, J. S., Bruckner‐Tuderman, L., Zillikens, D., Murrell, D. F., & Cowin, A. J. (2011) · The Journal of Pathology · doi:10.1002/path.2973 · Cited by 43
Self-citationvan Zeijl, C. J. J., van Koppen, C. J., Surovtseva, O. V., de Gooyer, M. E., Plate, R., Conti, P., Karstens, W.-J. F., Timmers, M., Saeed, P., Wiersinga, W. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2931 · Cited by 42
Commercial blot assays in the diagnosis of systemic rheumatic diseases
Ghirardello, A., Bendo, R., Rampudda, M., Bassi, N., Zampieri, S., & Doria, A. S. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.02.012 · Cited by 41
Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Müller, A., Fischer, A., Katus, H. A., & Kaya, Z. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150316123711 · Cited by 38
Self-citationPickens, B., Mao, Y., Li, D., Siegel, D. L., Poncz, M., Cines, D. B., & Zheng, X. L. (2015) · Blood · doi:10.1182/blood-2014-07-587139 · Cited by 37
Villalta, D., Sorrentino, M. C., Girolami, E., Tampoia, M., Alessio, M. G., Brusca, I., Daves, M., Porcelli, B., Barberio, G., & Bizzaro, N. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.024 · Cited by 37
B Cells: Programmers of CD4 T Cell Responses
Barr, T. A., Gray, M., & Gray, D. (2012) · Infectious Disorders - Drug Targets · doi:10.2174/187152612800564446 · Cited by 37
Rapoport, B., Aliesky, H. A., Banuelos, B., Chen, C., & McLachlan, S. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500126 · Cited by 37
Self-citationFuture perspectives in target-specific immunotherapies of myasthenia gravis
Dalakas, M. C. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615605700 · Cited by 37
Autoantibodies in lupus nephritis patients requiring renal transplantation
Stinton, L. M., Barr, S. G., Tibbles, L. A., Yilmaz, S., Sar, A., Benedikttson, H., & Fritzler, M. J. (2007) · Lupus · doi:10.1177/0961203307078391 · Cited by 35
Visualization of the thyrotropin receptor on the cell surface by potent autoantibodies.
de Forteza, R., Smith, C., Αmin, J., McKenzie, J. M., & Zakarija, M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.7909819 · Cited by 35
Ellebrecht, C. T., Srinivas, G., Bieber, K., Banczyk, D., Kalies, K., Künzel, S., Hammers, C. M., Baines, J. F., Zillikens, D., Ludwig, R. J., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.007 · Cited by 35
Self-citationAChR-specific immunosuppressive therapy of myasthenia gravis
Luo, J., & Lindstrom, J. M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.011 · Cited by 34
Self-citationRecke, A., Trog, L. M., Pas, H. H., Vorobyev, A., Abadpour, A., Jonkman, M. F., van Zandbergen, G., Kauderer, C., Zillikens, D., Vidarsson, G., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400160 · Cited by 34
Self-citationEstimation of Serum TSH Receptor Autoantibody Concentration and Affinity
Nakatake, N., Sanders, J. F., Richards, T., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.1077 · Cited by 34
Sweet and Sour: The Role of Glycosylation for the Anti-inflammatory Activity of Immunoglobulin G
Böhm, S., Kao, D., & Nimmerjahn, F. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_18 · Cited by 32
Self-citationAnti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis
Budding, K., van de Graaf, E. A., Kardol‐Hoefnagel, T., Erp, J. M. K., van Kessel, D. A., Dragun, D., Hack, C. E., & Otten, H. G. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.07.007 · Cited by 32
Tersteeg, C., Verhenne, S., Roose, E., Schelpe, A., Deckmyn, H., Meyer, S. F. D., & Vanhoorelbeke, K. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1122515 · Cited by 32
Self-citationReduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment
Hirose, M., Kasprick, A., Beltsiou, F., Dieckhoff, K. S., Schulze, F. S., Samavedam, U. K. S. R. L., Hundt, J. E., Pas, H. H., Jonkman, M. F., Schmidt, E., et al. (2016) · Molecular Medicine · doi:10.2119/molmed.2015.00206 · Cited by 32
Self-citationGeographical distribution of A seropositive myasthenia gravis population
Heldal, A. T., Eide, G. E., Gilhus, N. E., & Romi, F. R. (2011) · Muscle & Nerve · doi:10.1002/mus.23271 · Cited by 31
Seroprevalence of anti-N-methyl-d-aspartate receptor antibodies in women with ovarian teratoma
Mangler, M., Trebesch, I., Teegen, B., STÖCKER, W., Prüß, H., Meisel, A., Schneider, A., Vasiljeva, J., & Speiser, D. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7074-0 · Cited by 30
Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes
Mao, X., Cho, M. J. T., Ellebrecht, C. T., Mukherjee, E. M., & Payne, A. S. (2017) · JCI Insight · doi:10.1172/jci.insight.92253 · Cited by 30
Yu, X., Menard, M., Prechl, J., Bhakta, V., Sheffield, W. P., & Lazarus, A. H. (2015) · Blood · doi:10.1182/blood-2015-08-664656 · Cited by 29
PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita
Koga, H., Recke, A., Vidarsson, G., Pas, H. H., Jonkman, M. F., Hashimoto, T., Kasprick, A., Ghorbanalipoor, S., Tenor, H., Zillikens, D., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.619 · Cited by 29
Self-citationMolecular Interactions between the TSH Receptor and a Thyroid-Stimulating Monoclonal Autoantibody
Sanders, J. F., Miguel, R. N., Bolton, J., Bhardwaja, A., Sanders, P. W., Nakatake, N., Evans, M. K., Furmaniak, J., & Smith, B. R. (2007) · Thyroid · doi:10.1089/thy.2007.0041 · Cited by 28
van der Wier, G., Pas, H. H., Kramer, D., Diercks, G. F. H., & Jonkman, M. F. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.140 · Cited by 27
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy
Stanton, C., Mookadam, F., Cha, S., McNamara, D. M., Aukrust, P., Wojnicz, R., Bailey, K. R., & Cooper, L. T. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.016 · Cited by 27
Misharin, A. V., Nagayama, Y., Aliesky, H. A., Mizutori, Y., Rapoport, B., & McLachlan, S. M. (2009) · Endocrinology · doi:10.1210/en.2009-0181 · Cited by 27
Self-citationNakahara, M., Mitsutake, N., Sakamoto, H., Chen, C., Rapoport, B., McLachlan, S. M., & Nagayama, Y. (2010) · Endocrinology · doi:10.1210/en.2010-0315 · Cited by 25
Self-citationMyasthenia Gravis—Validation of a Hypothesis
Simpson, J. A. (1977) · Scottish Medical Journal · doi:10.1177/003693307702200305 · Cited by 25
The Importance of Autoantibody Detection in Primary Biliary Cirrhosis
Cançado, E. L. R., & Harriz, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00309 · Cited by 24
Nakahara, M., Johnson, K. T. M., Eckstein, A. K., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1846 · Cited by 24
Granieri, L., Marnetto, F., Valentino, P., Frau, J., Patanella, A. K., Nytrova, P., Sola, P., Capobianco, M., Jarius, S., & Bertolotto, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038896 · Cited by 24
Genetically Determined Severity of Anti-Myeloperoxidase Glomerulonephritis
Xiao, H., Ciavatta, D. J., Aylor, D. L., Hu, P., de Villena, F. P., Falk, R. J., & Jennette, J. C. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.12.006 · Cited by 24
Mueller, A., Brieske, C., Schinke, S., Csernok, E., Gross, W. L., Hasselbacher, K., Voswinkel, J., & Holl‐Ulrich, K. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4490 · Cited by 24
Autoimmune Myopathies: Where Do We Stand?
Simon, J.-P., Marié, I., Jouen, F., Boyer, O., & Martinet, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00234 · Cited by 24
Rosenberg, A. S., Pariser, A., Diamond, B., Yao, L. P., Turka, L. A., Lacaná, E., & Kishnani, P. S. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.02.009 · Cited by 23
Patel, P. P., Becker, J. L., Freyer, C. W., Griffiths, E. A., Thompson, J. E., & Wang, E. S. (2016) · Transfusion · doi:10.1111/trf.13465 · Cited by 23
Antigen-Specific Immunotherapeutic Vaccine for Experimental Autoimmune Myasthenia Gravis
Luo, J., & Lindstrom, J. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401392 · Cited by 22
Self-citationRapoport, B., Banuelos, B., Aliesky, H. A., Trier, N. H., & McLachlan, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601393 · Cited by 22
Self-citationThe Importance of Autoantibody Detection in Autoimmune Hepatitis
Cançado, E. L. R., Abrantes‐Lemos, C. P., & Terrabuio, D. R. B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00222 · Cited by 21
Specific immunotherapy of experimental myasthenia gravis by a novel mechanism
Luo, J., Kuryatov, A., & Lindstrom, J. M. (2009) · Annals of Neurology · doi:10.1002/ana.21901 · Cited by 21
Self-citationThe FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases
Sondermann, P. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0272-7 · Cited by 21
Self-citationThyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward
McLachlan, S. M., & Rapoport, B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02028.x · Cited by 18
Self-citationRademacher, J., Kill, A., Mattat, K., et al. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.150474 · Cited by 15
Zhao, L., Xu, C., & Xu, J. (2014) · Cardiology · doi:10.1159/000365782 · Cited by 13
Bratland, E., Bredholt, G., Mellgren, G., Knappskog, P. M., Mozes, E., & Husebye, E. S. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.018 · Cited by 9
Radzimski, C., Probst, C., Teegen, B., Rentzsch, K., Blöcker, I.-M., Dähnrich, C., Schlumberger, W., STÖCKER, W., Bogdanos, D. P., & Komorowski, L. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/572815 · Cited by 9
Self-citationKomuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Pathogenesis of autoimmune disease
Pisetsky, D. S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00720-1 · Cited by 649
Miller, F. W. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102266 · Cited by 516
Siglecs as Immune Cell Checkpoints in Disease
Duan, S., & Paulson, J. C. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-102419-035900 · Cited by 452
The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik, M., Sand, K. M. K., Hubbard, J. J., Andersen, J. T., Sandlie, I., & Blumberg, R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01540 · Cited by 429
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
Wang, X., Wu, X., Tan, B., Zhu, L., Zhang, Y., Lin, L., Xiao, Y., Sun, A., Wan, X., Liu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.027 · Cited by 320
Self-citation
Metadata
- Authors
- Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., Lindstrom, J. M., Lamprecht, P., Fischer, A., Riemekasten, G., Tersteeg, C., Sondermann, P., Rapoport, B., Wandinger, K.-P., Probst, C., El Beidaq, A., Schmidt, E., Verkman, A., Manz, R. A., & Nimmerjahn, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-05-31
- Volume
- 8
- Pages
- 603-603
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2617402993
- Cited by
- 469
- References
- 378
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.